Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $47.32 and traded as low as $33.96. Kewaunee Scientific shares last traded at $34.88, with a volume of 6,557 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.
Read Our Latest Report on Kewaunee Scientific
Kewaunee Scientific Price Performance
The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $107.06 million, a P/E ratio of 5.94 and a beta of 0.47. The company has a fifty day simple moving average of $38.52 and a two-hundred day simple moving average of $47.55.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The business had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
Insider Activity at Kewaunee Scientific
In other news, CEO Thomas David Hull III sold 3,000 shares of the stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $45.63, for a total value of $136,890.00. Following the completion of the sale, the chief executive officer now owns 37,916 shares of the company's stock, valued at approximately $1,730,107.08. This represents a 7.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Keith M. Gehl acquired 1,000 shares of the stock in a transaction dated Friday, April 4th. The shares were purchased at an average price of $35.00 per share, for a total transaction of $35,000.00. Following the completion of the purchase, the director now directly owns 18,500 shares in the company, valued at $647,500. The trade was a 5.71% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders sold 11,057 shares of company stock worth $440,326. 14.20% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Minerva Advisors LLC lifted its holdings in shares of Kewaunee Scientific by 4.1% during the fourth quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company's stock worth $6,668,000 after purchasing an additional 4,311 shares during the period. Invesco Ltd. bought a new stake in shares of Kewaunee Scientific in the 4th quarter valued at about $6,545,000. American Century Companies Inc. increased its stake in shares of Kewaunee Scientific by 43.4% in the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company's stock valued at $1,937,000 after buying an additional 14,889 shares during the period. O Shaughnessy Asset Management LLC raised its position in shares of Kewaunee Scientific by 3.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company's stock worth $1,733,000 after acquiring an additional 891 shares during the last quarter. Finally, Ritholtz Wealth Management lifted its stake in shares of Kewaunee Scientific by 42.2% in the first quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company's stock worth $707,000 after acquiring an additional 5,330 shares during the period. Institutional investors own 32.69% of the company's stock.
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.